跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,156 条关于
“AMI Pharm”
全部
11,156
临床试验
5,041
药物
1,168
机构
1,053
资讯
3,894
去年
AMI Pharm's AYP-101 Enters Phase 3 Trial for Non-Inflammatory Fat Reduction
去年
Myocardial Infarction Therapeutics Pipeline Shows Promise with Over 45 Companies Involved
5个月前
ST Pharm Secures First Japanese Patent for mRNA-LNP Platform Technology STP1244
去年
Hanmi Pharm Seeks Approval for Triple-Combination Hypertension Drug Amosartan PLUS-L
去年
REDUCE-AMI Trial Re-evaluates Beta-Blocker Use Post-Myocardial Infarction
6个月前
DOBERMANN Trials Test Early Interventions to Prevent Cardiogenic Shock in High-Risk AMI Patients
去年
Hanmi Pharm Accelerates Launch of Efpeglenatide for Obesity Treatment
上个月
Samchundang Pharm Reaches Global Settlement in Eylea Biosimilar Patent Dispute, Clearing Path for SCD411 Commercialization
9个月前
R-Pharm Advances Three Cancer Drugs Through Clinical Development, Including Novel Antiandrogen for Prostate Cancer
去年
R-Pharm Presents Long-Term Olokizumab Data Showing Sustained Improvement in Rheumatoid Arthritis Patients
第 1 页,共 390 页
上一页
下一页